[1] |
Bayat, A., I. Fijalkowski, T. Andersen, S. A. Abdulmunem, J. van den Ende and W. Van Hul. 2016. Further delineation of facioaudiosymphalangism syndrome: description of a family with a novel NOG mutation and without hearing loss. Am. J. Med. Genet. A 170, 1479-1484.
|
[2] |
Brown, D. J., T. B. Kim, E. M. Petty, C. A. Downs, D. M. Martin, P. J. Strouse, S. E. Moroi, S. S. Gebarski and M. M. Lesperance. 2003. Characterization of a stapes ankylosis family with a NOG mutation. Otol. Neurotol. 24, 210-215.
|
[3] |
Brown, D. J., T. B. Kim, E. M. Petty, C. A. Downs, D. M. Martin, P. J. Strouse, S. E. Moroi, J. M. Milunsky and M. M. Lesperance. 2002. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am. J. Hum. Genet. 71, 618-624.
|
[4] |
Brunet, L. J., J. A. McMahon, A. P. McMahon and R. M. Harland. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-1457.
|
[5] |
Declau, F., J. Van den Ende, E. Baten and P. Mattelaer. 2005. Stapes ankylosis in a family with a novel NOG mutation: otologic features of the facioaudiosymphalangism syndrome. Otol. Neurotol. 26, 934-940.
|
[6] |
Dixon, M. E., P. Armstrong, D. B. Stevens and M. Bamshad. 2001. Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism. Genet. Med. 3, 349-353.
|
[7] |
Gong, Y., D. Krakow, J. Marcelino, D. Wilkin, D. Chitayat, R. Babul-Hirji, L. Hudgins, C. W. Cremers, F. P. Cremers, H. G. Brunner, K. Reinker, D. L. Rimoin, D. H. Cohn, F. R. Goodman, W. Reardon, M. Patton, C. A. Francomano and M. L. Warman. 1999. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat. Genet. 21, 302-304.
|
[8] |
Hwang, C. H. and D. K. Wu. 2008. Noggin heterozygous mice: an animal model for congenital conductive hearing loss in humans. Hum. Mol. Genet. 17, 844-853.
|
[9] |
Lehmann, K., P. Seemann, F. Silan, T. O. Goecke, S. Irgang, K. W. Kjaer, S. Kjaergaard, M. J. Mahoney, S. Morlot, C. Reissner, B. Kerr, A. O. Wilkie and S. Mundlos. 2007. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am. J. Hum. Genet. 81, 388-396.
|
[10] |
Marcelino, J., C. M. Sciortino, M. F. Romero, L. M. Ulatowski, R. T. Ballock, A. N. Economides, P. M. Eimon, R. M. Harland and M. L. Warman. 2001. Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc. Natl. Acad. Sci. U. S. A. 98, 11353-11358.
|
[11] |
McMahon, J. A., S. Takada, L. B. Zimmerman, C. M. Fan, R. M. Harland and A. P. McMahon. 1998. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 12, 1438-1452.
|
[12] |
Pang, X., Z. Wang, Y. Chai, H. Chen, L. Li, L. Sun, H. Jia, H. Wu and T. Yang. 2015. A novel missense mutation of NOG interferes with the dimerization of NOG and causes proximal symphalangism syndrome in a Chinese family. Ann. Otol. Rhinol. Laryngol. 124, 745-751.
|
[13] |
Potti, T. A., E. M. Petty and M. M. Lesperance. 2011. A comprehensive review of reported heritable noggin-associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG-related-symphalangism spectrum disorder (NOG-SSD). Hum. Mutat. 32, 877-886.
|
[14] |
Richards, S., N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W. W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H. L. Rehm and A. L. Q. A. Committee. 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405-424.
|
[15] |
Smith, W. C., A. K. Knecht, M. Wu and R. M. Harland. 1993. Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature 361, 547-549.
|
[16] |
Usami, S., S. Abe, S. Nishio, Y. Sakurai, H. Kojima, T. Tono and N. Suzuki. 2012. Mutations in the NOG gene are commonly found in congenital stapes ankylosis with symphalangism, but not in otosclerosis. Clin. Genet. 82, 514-520.
|
[17] |
Vesell, E. S. 1960. Symphalangism, strabismus and hearing loss in mother and daughter. N. Engl. J. Med. 263, 839-842.
|
[18] |
Vincent, R., I. Wegner, D. M. Kamalski, A. J. Bittermann and W. Grolman. 2016. Congenital stapes ankylosis in children: surgical findings and results in 35 cases. Otol. Neurotol. 37, 367-373.
|
[19] |
Wu, X. L., M. M. Gu, L. Huang, X. S. Liu, H. X. Zhang, X. Y. Ding, J. Q. Xu, B. Cui, L. Wang, S. Y. Lu, X. Y. Chen, H. G. Zhang, W. Huang, W. T. Yuan, J. M. Yang, Q. Gu, J. Fei, Z. Chen, Z. M. Yuan and Z. G. Wang. 2009. Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene. Am. J. Hum. Genet. 85, 53-63.
|
[20] |
Yang, W., L. Cao, W. Liu, L. Jiang, M. Sun, D. Zhang, S. Wang, W. H. Lo, Y. Luo and X. Zhang. 2008. Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism. J. Hum. Genet. 53, 368-374.
|